Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 59-63, January 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Keating, K. M.
Right arrow Articles by Roess, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Keating, K. M.
Right arrow Articles by Roess, D. A.

Glucocorticoid Effects on Lipid Lateral Diffusion and Membrane Composition in Lipopolysaccharide-activated B-Cell Leukemia 1 Cells1

Kathleen M. Keating, B. George Barisas and Deborah A. Roess2

Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, Connecticut 06510; and Department of Chemistry and Microbiology and of Physiology, Colorado State University, Fort Collins, Colorado 80523

We have investigated the effects of glucocorticoid treatment on lipid lateral diffusion and cholesterol:phospholipid ratios in the plasma membranes of the lipopolysaccharide (LPS)-responsive murine B-cell leukemia (BCL1). Exposure to LPS for 24 h at concentrations of 50 µg/ml, 100 µg/ml, and 250 µg/ml caused a 42% reduction in the lateral diffusion of the lipid probe 3,3'-dioctadecylindocarbocyanine iodide as measured by fluorescence photobleaching recovery techniques at 37°C. In cells incubated with 50 µg/ml LPS, 3,3'-dioctadecylindocarbocyanine iodide diffusion is reduced to 2.2 x 10-9 cm2s-1 compared to freshly isolated BCL1 cells where 3,3'-dioctadecylindocarbocyanine iodide diffused at a rate of 3.8 x 10-9 cm2s-1. In BCL1 cells activated by LPS for 24 h and recultured with a pharmacological concentration of the synthetic glucocorticoid triamcinolone acetonide (TA, 10-6 M) for 6 h, lipid lateral diffusion increased to 3.5 x 10-9 cm2s-1. Concentrations of TA lower than 10-6 M had no effect on lipid lateral diffusion. Six-h treatment with 10-6 M TA had no effect on freshly isolated BCL1 cells (Time 0). However, lipid lateral diffusion increased in cells incubated 24, 48, and 72 h with LPS, and an additional 6 h with 10-5 M TA suggested that activated BCL1 cells were more glucocorticoid sensitive than cells at Time 0. Plasma membrane cholesterol and phospholipid content, analyzed at 0 and 24 h, indicated that LPS activation was associated with a 7% increase in the cholesterol:phospholipid ratio in BCL1 membranes and that glucocorticoid treatment of these LPS-activated cells for 6 h decreased the membrane cholesterol:phospholipid ratio perhaps through inhibition of de novo cholesterol synthesis.

1 This work was supported by NIH AI-21873 (B. G. B.), by NIH HD 23236 (D. A. R.), and by the United States Department of Agriculture Animal Health and Disease program.

2 To whom requests for reprints should be addressed, at the Department of Physiology, Colorado State University, Fort Collins, CO 80523.

Received 4/21/87. Revised 9/ 1/87. Accepted 10/ 7/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.